Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Zeesan
company
About
Zeesan is a biomedical company that specializes in the development and production of molecular diagnostics kits.
- 51 - 100
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- ¥30.80M
- Industries
- Biotechnology,Health Diagnostics,Medical
- Founded date
- Jun 12, 2010
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
¥45.80M $10M
Zeesan has raised a total of
¥45.80M $10M
in funding over 2 rounds. Their latest funding was raised on
Jun 7, 2021 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 7, 2021 | Post-IPO Equity | $10M | 3 | — | — | Detail |
| Jul 28, 2015 | Post-IPO Equity | ¥30.80M | 2 | — | — | Detail |
| Feb 19, 2014 | Series A | ¥10M | 1 | — | — | Detail |
| Feb 16, 2012 | Angel | ¥5M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
6
Zeesan is funded by 6 investors.
Qianhai Dingfeng Investment
and Xuankai Touzi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Equity |
|
|
— | Post-IPO Equity |
|
|
— | Post-IPO Equity |
|
|
— | Post-IPO Equity |
Dingfeng Asset
|
— | Post-IPO Equity |
HY Venture
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
